Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and sodium salicylate

acetylleucyl-leucyl-norleucinal has been researched along with sodium salicylate in 1 studies

Compound Research Comparison

Studies
(acetylleucyl-leucyl-norleucinal)
Trials
(acetylleucyl-leucyl-norleucinal)
Recent Studies (post-2010)
(acetylleucyl-leucyl-norleucinal)
Studies
(sodium salicylate)
Trials
(sodium salicylate)
Recent Studies (post-2010) (sodium salicylate)
3210532,03150171

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McEver, RP; Pan, J; Xia, L; Yao, L1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and sodium salicylate

ArticleYear
A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells.
    Blood, 1998, Mar-01, Volume: 91, Issue:5

    Topics: Animals; Antioxidants; Aorta; Cattle; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytokines; Dexamethasone; Endothelium, Vascular; Gene Expression; Humans; Interleukin-4; Leupeptins; NF-kappa B; Oncostatin M; P-Selectin; Peptides; Pyrrolidines; Sodium Salicylate; Thiocarbamates; Umbilical Veins

1998